v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash $ 1,240 $ 74,631
Prepaid expenses 80,375 160,750
Prepaid expenses - research and development 209,427
Subscription receivable 50,000
Other current assets 1,404 1,119
Total Assets 292,446 286,500
Current Liabilities:    
Accounts payable 1,929,223 1,888,729
Accrued compensation 1,092,413 1,067,777
Financing liability 314,985 314,985
Accrued dividend payable 359,453 7,205
Total Liabilities 20,428,481 18,824,336
Commitments and contingencies (Note 8)
Stockholders’ Deficiency:    
Common Stock, $0.001 par value, 200,000,000 shares authorized; 45,038,244 shares issued and outstanding as of March 31, 2025 and December 31, 2024 45,038 45,038
Additional paid-in capital 27,478,662 27,595,010
Accumulated deficit (47,661,881) (46,180,030)
Total Stockholders’ Deficiency (20,136,035) (18,537,836)
Total Liabilities and Stockholders’ Deficiency 292,446 286,500
Series A Convertible Preferred Stock [Member]    
Stockholders’ Deficiency:    
Preferred stock, value 1,342 1,342
Series B Convertible Preferred Stock [Member]    
Stockholders’ Deficiency:    
Preferred stock, value 267 267
Series C Convertible Preferred Stock [Member]    
Stockholders’ Deficiency:    
Preferred stock, value 537 537
Nonrelated Party [Member]    
Current Liabilities:    
Accrued expenses 1,441,697 1,115,501
Accrued interest 1,168,356 973,436
Notes payable 1,177,343 1,175,864
Convertible notes payable 966,707 986,500
Warrant liabilities 89,118 86,972
Derivative liabilities 543,997 479,844
Advances payable - related party 194,375 194,375
Related Party [Member]    
Current Liabilities:    
Accrued expenses 217,000 202,500
Accrued interest 2,193,741 1,994,418
Notes payable 795,345 443,750
Convertible notes payable 7,561,708 7,561,708
Warrant liabilities 131,792 129,113
Derivative liabilities 151,228 101,659
Advances payable - related party $ 100,000 $ 100,000